Why this matters
Coming off a GLP-1 medication is the most under-discussed part of the program. Long-term clinical data shows that most patients regain a meaningful share of the weight they lost when the medication is stopped abruptly and behaviour structure isn’t in place. The good news: a structured taper combined with deliberate behaviour anchoring meaningfully reduces the rebound. The taper is the easy part. The behaviour structure is the work.
Nothing here replaces the guidance of your prescribing clinician. Any plan to stop should be coordinated with them.
Why the rebound happens
GLP-1 medications work, in part, by suppressing appetite signaling and slowing gastric emptying. When you stop, both of those effects fade over a few weeks. Hunger returns to its previous baseline. If your eating habits during treatment relied on the medication to do the heavy lifting — without parallel structural changes — the calorie pattern that built the original weight gain returns. This is biology, not failure.
The taper protocol
The protocol our medical reviewers recommend for elective discontinuation, in coordination with your clinician:
- Weeks 1–4: hold maintenance dose, finalize the behaviour structure (see below).
- Weeks 5–8: reduce to the next-lowest dose. Continue behaviour structure.
- Weeks 9–12: reduce to the starting dose (e.g., 0.25mg semaglutide).
- Weeks 13–16: dose every other week.
- Week 17 onward: stop, with a check-in at week 4 and week 12 post-discontinuation.
Some patients tolerate a faster taper; others need a slower one. The goal isn’t speed — it is preserving the loss.
Protecting the loss
The structural changes that protect weight loss after discontinuation:
- Protein floor. 0.8–1.0 g per kg body weight, every day, at every meal.
- Resistance training. Two to three sessions weekly. Preserves muscle mass that the rapid loss may have eroded.
- Sleep target. Seven or more hours. Sleep debt drives appetite hormones in the wrong direction.
- Daily protein-forward breakfast. The single highest-leverage habit in our reader survey.
- Weekly weigh-in. Same day, same time. Not daily — weekly is enough to catch a meaningful trend.
Monitoring after stopping
Schedule a follow-up with your clinician at four weeks, twelve weeks, and six months post-discontinuation. The signals that should trigger an earlier conversation:
- 5+ lb regain in any 30-day window.
- Return of pre-treatment metabolic symptoms.
- Inability to maintain the behaviour structure for two consecutive weeks.
For many patients, the right answer is a low maintenance dose long-term rather than complete discontinuation. That decision is between you and your prescriber.